Image

Global Antimicrobials Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Pharmaceutical
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Antimicrobials Market, By Type (Antibacterial, Antifungal, Antiviral, Others), Origin (Natural, Semi-Synthetic, Synthetic), Dosage (Powder, Tablet, Solution, Liquid, Others), Route of Administration (Oral, Topical, Parenteral Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Industry Trends and Forecast to 2029

Antimicrobials Market

Global Antimicrobials Market Analysis and Size

In recent years, the antimicrobials market is anticipated to grow rapidly. The change in growth trajectory is primarily due to enterprises stabilizing their output following the COVID-19 pandemic when demand rose dramatically. With the exponential proliferation of coronavirus, the worldwide antimicrobials market is expected to witness a significant increase. In addition to this, a high prevalence rate of various bacterial diseases will result in introducing antimicrobials in the market. 

  • Antimicrobials are one of the most effective types of chemotherapy, and they have been used to protect humans from infectious infections. Microorganisms are killed or slowed by antimicrobial agents. Bacteria, viruses, protozoans, and fungus such as mold and mildew are forms of microorganisms.
  • Data Bridge Market Research analyses that the antimicrobials market was valued at USD 39.56 billion in 2021 and is expected to reach USD 60.71 billion by 2029, registering a CAGR of 5.50% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Antimicrobials Market Dynamics

Drivers

  • Increase in the prevalence rate of bacterial infections

The rising prevalence of bacterial infections such as tuberculosis, respiratory infections, urinary tract infections (UTI), skin infections and others will enhance the growth of global antimicrobials market.    

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of antimicrobials market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness and growing government funding to improve patient care are the factors that will expand the antimicrobials market. Other factors such as high disposable income and a sedentary lifestyle will positively impact the antimicrobials market's growth rate. Additionally, increasing population of geriatric people will result in the expansion of antimicrobials market. The advancement in medical technology will act as a major driver that will result in the expansion of the growth rate of the treatment market.

Opportunities

  • Rise in the investment for R&D by public and private organizations

The rise in the research and development activities and increasing investments by government and private organization will boost new opportunities for the market's growth rate.

Moreover, continuous economic development and introduction of blockbuster therapeutics will escalate the growth rate antimicrobials market in the future.

Restraints/Challenges Global Antimicrobials Market

However, high cost associated with the antimicrobials and lack of infrastructure in low-income countries will impede the growth rate of antimicrobials market. Additionally, side effects of antimicrobials will hinder the antimicrobials market growth. The lack of awareness and increasing demand for alternative medicines involving naturopathy and homeopathy will further challenge the market in the forecast period mentioned above.

This antimicrobials market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on antimicrobials market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Antimicrobials market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Antimicrobials Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Due to the financial crisis and the delay in specialty healthcare delivery while prioritizing COVID-19-related treatments, healthcare systems around the world have been severely disrupted in the aftermath of the coronavirus pandemic. The COVID-19 had an impact on the global pharmaceutical supply chain, as well as the antimicrobials market. On the other hand, many antibiotics were initially used to treat COVID-19 and were widely prescribed and tested as a COVID-19 treatment.

Recent Development

  • In October 2021, the cephalosporin antibiotics business of GSK has been acquired by Sandoz, a Novartis company. It now owns rights to three well-known products (Zinnat, Zinacef, and Fortum) in over 100 countries, solidifying its position as the world's premier antibiotics company.

Global Antimicrobials Market Scope

The antimicrobials market is segmented on the basis of type, origin, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Antibacterial
  • Antifungal
  • Antiviral
  • Others

On the basis of type, the antimicrobials market is segmented into antibacterial, antifungal, antiviral and others. Antibacterial can be further segmented into macrolides, beta-lactams, quinolones and others.

Origin

  • Natural
  • Semi-Synthetic
  • Synthetic

On the basis of origin, the antimicrobials market is segmented into natural, semi-synthetic and synthetic.

Dosage

  • Powder
  • Tablet
  • Solution
  • Liquid
  • Others

On the basis of dosage, the antimicrobials market is segmented into powder, tablet, solution, liquid, and others.  

Route of Administration

  • Oral
  • Topical
  • Parenteral
  • Others

On the basis of route of administration, the antimicrobials market is segmented into oral, topical, parenteral and others.

End Users

  • Clinic
  • Hospital
  • Others

On the basis of end-users, the antimicrobials market is segmented into clinic, hospital and others.

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

The antimicrobials market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Antimicrobials Market Regional Analysis/Insights

The antimicrobials market is analysed and market size insights and trends are provided by country, type, origin, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the antimicrobials market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the antimicrobials market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and technological advancement in this region.

Europe is estimated to be the second-largest growing region of antimicrobials market owing to the high investment in R&D activities and well-established healthcare infrastructure.

Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increasing prevalence of infectious diseases, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Antimicrobials Market Share Analysis

The antimicrobials market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to antimicrobials market.

Some of the major players operating in the antimicrobials market are Abbott, AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Mylan N.V., Aurobindo Pharma, Cipla Inc., Sun Pharmaceutical Industries Ltd, Amneal Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Lupin, Novartis AG, Zydus Cadila, Bausch Health Companies Inc., Johnson & Johnson Private Limited, Dr. Reddy’s Laboratories Ltd., and AbbVie Inc., among others.

Research Methodology : Global Antimicrobials Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-antimicrobials-market


SKU-
Why Choose Us


Frequently Asked Questions

The Antimicrobials Market will be projected to grow at a CAGR of 5.50% during the forecast period of 2022 to 2029.
The Antimicrobials Market is projected at USD 60.71 billion during the forecast period of 2022 to 2029.
Increase in the prevalence rate of bacterial infections, Increasing investment for healthcare infrastructure and advancement in medical technology are the significant factors flourishing the growth of the Antimicrobials Market.
The major players operating in the antimicrobials market are Abbott, AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Mylan N.V., Aurobindo Pharma, Cipla Inc., Sun Pharmaceutical Industries Ltd, Amneal Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Lupin, Novartis AG, Zydus Cadila, Bausch Health Companies Inc., Johnson & Johnson Private Limited, Dr. Reddy’s Laboratories Ltd., and AbbVie Inc., among others.